ARCHIVES

NCI funds biorepository for prostate cancer SPOREs.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

In Brief: GAO Studying Cancer Program So Congress Will Have Own Data; NCI Job Freeze Still Hurts Program

February 21, 1975

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

NCI FY 1986 Bypass Budget Asks 41.445 Billion with Major Increase Tied To Goal for Year 2000

May 18, 1984

In Brief: Cancer Program Bill Renews Congressional Commitment To Principles, Rep. Carter Says

May 5, 1978